申请人:BEETLEBUNG PHARMA LTD.
公开号:US20210009549A1
公开(公告)日:2021-01-14
Cannavinoid derivatives, such as cannabidiol (CBD), desoxy-CBD, and desoxy-Δ
9
-tetrahydrocannabinol (desoxy-THC) derivatives, or an enantiomer, diastereomer, racemate, or pharmaceutically acceptable salt thereof, are useful for neuroprotection, treating pain, or treating a disease associated with alpha-1 glycine receptor (α1GlyR) and/or alpha-3 glycine receptor (α3GlyR) deficiency. Drug conjugates of the derivatives can be made.